Subrata Chakrabarti obtained his medical degree from India. Following completion of a Diploma in Ophthalmology, he moved to Canada. He obtained M.Sc and PhD at the University of Manitoba. He then did residency training in anatomical pathology at the University of Manitoba. Following a fellowship at Yale University, he joined University of Western Ontario, Canada. Currently, he is a distinguished University professor and an anatomical Pathologist at London Health Sciences Centre. Dr. Chakrabarti is an active educator. He also served as Chair/Chief of Pathology and Laboratory Medicine at Western University and London Health Sciences Centre from 2111-2021.
Dr. Chakrabarti’s research focuses on diabetic retinopathy and other chronic diabetic complications. He has published more than 280 research articles, reviews and book chapters. He has a h-Index of 76. His research is funded by several external agencies. His current research focus is epigenetics and non-coding RNAs in diabetic complications He developed a technology to treat diabetic retinopathy targeting long non-coding RNA HOTAIR, which can potentially be used as an eye-drop. In parallel he developed a serum-based biomarker panel as a diagnostic and prognostic biomarker for diabetic retinopathy. Recently he started a biotechnology company i-RNA Corp (i-RNA.ca) to commercialize this technology.